Research ArticleOriginal Research

Increased Collagen, Per Se, May Not Affect Left Ventricular Function in Spontaneously Hypertensive Rats

Dinko Susic and Edward D. Frohlich
Ochsner Journal September 2011, 11 (3) 241-245;

REFERENCES

  1. 1.↵
    1. Weber KT
    (1989) Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13(7):1637–1652, pmid:2656824.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Swynghedauw B
    (1999) Molecular mechanisms of myocardial remodeling. Physiol Rev 79(1):215–262, pmid:9922372.
    OpenUrlPubMedWeb of Science
  3. 3.↵
    1. Spinale FG
    (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87(4):1285–1342, pmid:17928585.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Weber KT
    (2000) Targeting pathological remodeling: concepts of cardioprotection and reparation. Circulation 102(12):1342–1345, pmid:10993849.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Jugdutt BI
    (2003) Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Curr Drug Targets Cardiovasc Haematol Disord 3(1):1–30, pmid:12769643.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Frohlich ED,
    2. González A,
    3. Díez J
    (2011) Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy. J Hypertens 29(1):17–26, pmid:21045723.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Briest W,
    2. Hölzl A,
    3. Rassler B,
    4. Deten A,
    5. Baba HA,
    6. Zimmer HG
    (2003) Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts. Cardiovasc Res 57(2):379–387, pmid:12566110.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Varagic J,
    2. Frohlich ED,
    3. Díez J,
    4. et al.
    (2006) Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am J Physiol Heart Circ Physiol 290(4):H1503–H1509, pmid:16299266.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Susic D,
    2. Varagic J,
    3. Ahn J,
    4. Matavelli L,
    5. Frohlich ED
    (2007) Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. Am J Physiol Heart Circ Physiol 292(1):H175–H179, pmid:16905598.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Susic D,
    2. Varagic J,
    3. Frohlich ED
    (1999) Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats. J Hypertens 17(8):1209–1215, pmid:10466478.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Armitage P,
    2. Berry G
    (1994) Statistical Methods in Medical Research. 3rd ed (Blackwell Scientific, Oxford, UK).
  12. 12.↵
    1. Lamparter S,
    2. Slight SH,
    3. Weber KT
    (2002) Doxycycline and tissue repair in rats. J Lab Clin Med 139(5):295–302, pmid:12032490.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Weber KT,
    2. Brilla CG
    (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83(6):1849–1865, pmid:1828192.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Jalil JE,
    2. Doering CW,
    3. Janicki JS,
    4. Pick R,
    5. Shroff SG,
    6. Weber KT
    (1989) Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64(6):1041–1050, pmid:2524288.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Camelliti P,
    2. Borg TK,
    3. Kohl P
    (2005) Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 65(1):40–51, pmid:15621032.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Pfeffer JM,
    2. Pfeffer MA,
    3. Braunwald E
    (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57(1):84–95, pmid:3891127.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Díez J,
    2. Frohlich ED
    (2010) A translational approach to hypertensive heart disease. Hypertension 55(1):1–8, pmid:19933923.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Susic D,
    2. Nunez E,
    3. Hosoya K,
    4. Frohlich ED
    (1998) Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats. J Hypertens 16(2):231–237, pmid:9535151.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.
    1. Varagic J,
    2. Frohlich ED,
    3. Susic D,
    4. et al.
    (2008) AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol Heart Circ Physiol 294(2):H853–H858, pmid:18055516.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Susic D,
    2. Varagic J,
    3. Frohlich ED
    (2010) Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess. Am J Physiol Heart Circ Physiol 298(4):H1177–H1181, pmid:20118410.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Norton GR,
    2. Tsotetsi J,
    3. Trifunovic B,
    4. Hartford C,
    5. Candy GP,
    6. Woodiwiss AJ
    (1997) Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 96(6):1991–1998, pmid:9323091.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Badenhorst D,
    2. Maseko M,
    3. Tsotetsi OJ,
    4. et al.
    (2003) Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovasc Res 57(3):632–641, pmid:12618225.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Asif M,
    2. Egan J,
    3. Vasan S,
    4. et al.
    (2000) An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci U S A 97(6):2809–2813, pmid:10706607, Erratum in: Proc Natl Acad Sci U S A. 2000;97(10):5679.
    OpenUrlAbstract/FREE Full Text
  24. 24.
    1. Susic D,
    2. Varagic J,
    3. Ahn J,
    4. Frohlich ED
    (2004) Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats. Am J Hypertens 17(4):328–333, pmid:15062886.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Susic D
    (2007) Cross-link breakers as a new therapeutic approach to cardiovascular disease. Biochem Soc Trans 35(Pt 5):853–856, pmid:17956231.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Brower GL,
    2. Gardner JD,
    3. Forman MF,
    4. et al.
    (2006) The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg 30(4):604–610, pmid:16935520.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Cingolani OH,
    2. Yang XP,
    3. Liu YH,
    4. Villanueva M,
    5. Rhaleb NE,
    6. Carretero OA
    (2004) Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats. Hypertension 43(5):1067–1073, pmid:15023934.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. de Simone G,
    2. de Divitiis O
    (2002) Extracellular matrix and left ventricular mechanics in overload hypertrophy. Adv Clin Path 6(1):3–10.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords